UPDATE: UK Pharmaceutical company AstraZeneca has rejected a buyout bid from US company Pfizer.
AstraZeneca rejects takeover bid Chairman says bid would “dramatically dilute” shareholders exposure UK, Sweden and US projects remain company’s focus IN A statement released this morning, AstraZeneca said the “financial and other terms” proposed in Pfizer’s original offer were “inadequate” and “substantially undervalued” AstraZeneca. Commenting on the decision by the AstraZeneca board of directors to turn…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
